Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Aselage Steve
Relationship:   Director
City:   Fremont
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   293,421    

Indirect Shares

  22,000      
Direct Value   $7,031,645    

Indirect Value

  $169,660      
Total Shares   315,421      
Total Value   $7,201,305      


Cti Biopharma Corporation
 $219,369 Biomarin Pharmaceutical Inc
 $5,231,829 Travere Therapeutics, Inc
 $1,150,376 Biocryst Pharmaceuticals Inc
 $430,072 Cti Biopharma Corporation
 $219,369 Biomarin Pharmaceutical Inc
 $5,231,829 Travere Therapeutics, Inc
 $1,150,376 Biocryst Pharmaceuticals Inc
 $430,072
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    5   
    5    

     Stock price went up :

    1   
    3    
     Stock price went down :
    4   
    2    
   
     Gain/Loss Ratio :
   0.0   
   1.5   
     Percentage Gain/Loss :
   -23.4%
 62.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cti Biopharma Corporation CTIC EVP, Global Commercial... 2005-06-30 24,133 2004-08-03 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Business Of... 2012-07-02 59,030 2006-04-28 0    Premium*  
            Travere Therapeutics, Inc TVTX Director 2022-05-11 146,919 2021-11-05 19,500    Premium*  
            Acer Therapeutics Inc ACER Director 2023-11-17 0 2017-09-19 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2024-05-24 63,339 2024-05-24 2,500    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Ops   •       –      –    2006-11-29 4 S $17.23 $86,150 D/D (5,000) 2,829 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2007-08-10 4 S $20.21 $405,389 D/D (20,000) 4,895 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2007-09-14 4 S $22.40 $224,000 D/D (10,000) 4,895 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2008-03-03 4 S $38.00 $1,520,000 D/D (40,000) 32,034 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-05-02 4 S $37.75 $143,450 D/D (3,800) 44,865 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-05-06 4 S $37.75 $611,550 D/D (16,200) 28,665 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-02 4 S $21.00 $210,000 D/D (10,000) 41,271 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-03 4 S $21.00 $210,000 D/D (10,000) 31,271 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-04 4 S $21.50 $107,500 D/D (5,000) 50,361 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-05 4 S $21.95 $140,831 D/D (6,416) 43,945 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-08 4 S $22.11 $532,526 D/D (24,090) 19,855 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-09-08 4 S $22.00 $770,000 D/D (35,000) 37,587 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-11-17 4 S $25.80 $12,900 D/D (500) 61,256 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-11-17 4 S $25.75 $206,000 D/D (8,000) 29,881 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-11-18 4 S $25.87 $811,546 D/D (31,375) 29,881 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-03 4 S $27.15 $279,895 D/D (10,311) 31,478 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-25 4 S $27.00 $247,779 D/D (9,177) 43,978 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-26 4 S $27.00 $1,093,828 D/D (40,512) 43,978 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2012-05-11 4 S $37.07 $989,348 D/D (26,160) 59,030 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2012-05-15 4 S $38.64 $386,373 D/D (10,000) 59,030 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2016-11-21 4 S $21.00 $105,000 D/D (5,000) 243,756 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2016-11-22 4 S $21.30 $68,160 D/D (3,200) 240,556 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2017-06-14 4 S $17.85 $89,250 D/D (5,000) 245,556 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-12-07 4 S $24.04 $240 D/D (10) 251,523 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-03-05 4 S $15.36 $66,939 D/D (4,359) 256,357 0 %

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed